During the past decade, Inner Mongolia People's Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inner Mongolia People's Hospital" #1 sponsor was "Betta Pharmaceuticals Co., Ltd." with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Tasly Biopharmaceuticals Co., Ltd." with 2 trials sponsored, "The George Institute" with 2 trials sponsored and "Akeso" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inner Mongolia People's Hospital" #1 collaborator was "Beijing Children's Hospital" with 1 trials as a collaborator, "Beijing Municipal Administration of Hospital, China" with 1 trials as a collaborator, "Beijing Tiantan Hospital" with 1 trials as a collaborator, "BioShin Limited" with 1 trials as a collaborator and "CCRF Consulting Co., Ltd." with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Inner Mongolia People's Hospital" are "Acute Ischemic Stroke" (3 trials), "Acute Ischaemic Stroke" (2 trials), "Chronic Cough" (2 trials), "Abnormal Mucus Secretions" (1 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "Inner Mongolia People's Hospital" in a lesser frequency.

Most popular intervention types in "Inner Mongolia People's Hospital" are "Drug" (19 trials), "Device" (3 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Aspirin" (2 trials), "Gefapixant 15 mg BID" (2 trials), "Recombinant human urokinase" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Inner Mongolia People's Hospital" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Inner Mongolia People's Hospital". 1 are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Inner Mongolia People's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Inner Mongolia People's Hospital, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".